| 000 | 01558 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515170023.0 | ||
| 264 | 0 | _c20090728 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1421-9794 | ||
| 024 | 7 |
_a10.1159/000214143 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSomali, Isil | |
| 245 | 0 | 0 |
_aCisplatin plus gemcitabine chemotherapy in taxane/anthracycline-resistant metastatic breast cancer. _h[electronic resource] |
| 260 |
_bChemotherapy _c2009 |
||
| 300 |
_a155-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnthracyclines _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aBridged-Ring Compounds _xtherapeutic use |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTaxoids _xtherapeutic use |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aAlacacioglu, Ahmet | |
| 700 | 1 | _aTarhan, Mustafa Oktay | |
| 700 | 1 | _aMeydan, Nezih | |
| 700 | 1 | _aErten, Cigdem | |
| 700 | 1 | _aUsalp, Songul | |
| 700 | 1 | _aYilmaz, Ugur | |
| 773 | 0 |
_tChemotherapy _gvol. 55 _gno. 3 _gp. 155-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000214143 _zAvailable from publisher's website |
| 999 |
_c18820908 _d18820908 |
||